Roche uses K+N for cold chain in Greece

LinkedIn +

Pharmaceutical giant Roche has taken on Kuehne + Nagel to transport its products which have to be kept within clearly defined temperature ranges throughout the entire transport process in Greece in order to cut emissions.

These products typical have to remain within +2°C and +8°C and between +15°C and +25°C, and are usually transported by airfreight even over relatively short distances.

Kuehne + Nagel worked with Roche to develop a guaranteed unbroken refrigeration chain based on its “KN PharmaChain” product, which is certified in accordance with Good Distribution Practice-Standards.

Shipments from various Roche production plants are consolidated by Kuehne + Nagel and transported to Greece under temperature controlled conditions. Refrigerated trailers permit exact temperature control and efficient double-stack loading.

Much less fuel is used to cover the smae distance as previous air transport operations, and the passive temperature control packing, which was previously required, is no longer needed.

CO2 emissions have been reduced by around 85 per cent. The remaining CO2 is offset by a project of the organisation myclimate, which is being financed with a one-time payment by Kuehne + Nagel.

“The implementation of this project is the result of a close partnership in the fields of sustainability and green logistics… This clearly shows that Roche and Kuehne + Nagel do more than pay lip service to the protection of the environment,” said Dirk Reich, executive vice president and member of the management board of Kuehne + Nagel.

Share this story: